Tag: FDA IMA

Mabwell Announces IND Application Acceptance for CDH17-Targeting ADC 7MW4911 from Both NMPA and FDA

SHANGHAI, Aug. 1, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its proprietary CDH17-targeting antibody-drug conjugate (ADC), 7MW4911,...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Name

This field is for validation purposes and should be left unchanged.

HomeTagsFDA IMA

TwentyOneVC Redefines Retail Investing with Advanced Tools for Smarter Financial Decisions

Launch of Global Impact Champions Awards for Financial Health

Bitcoin Swift Launches Stage 3 Presale With AI-Driven Proof-of-Yield Rewards System

Tag: FDA IMA

Mabwell Announces IND Application Acceptance for CDH17-Targeting ADC 7MW4911 from Both NMPA and FDA

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us